GILD+30.93%20.0%
MRNA+567.66%20.0%
NVAX+11.47%20.0%
PCVX+40.74%20.0%
PFE+2.71%20.0%
As of Oct 2, 2026, 9:55 PM ET
MedTech Short '25: Vaccine Makers Constituents
Gilead Sciences, Inc.GILD | 20.0% | -1.87% | -5.18% | -3.24% | -1.86% | 17.94% | -2.81% | 29.38% | 30.93% | 74.62% | 142.76% | $179.47B |
Moderna, Inc.MRNA | 20.0% | 0.57% | 3.75% | 25.60% | 0.25% | 542.30% | 253.58% | 583.32% | 567.66% | 211.13% | -44.29% | $75.39B |
Novavax, Inc.NVAX | 20.0% | -1.32% | -1.71% | 3.15% | 0.42% | 58.41% | 4.98% | 78.01% | 11.47% | -27.46% | -94.24% | $1.72B |
Pfizer Inc.PFE | 20.0% | -1.14% | -0.41% | -4.15% | -1.08% | 11.71% | 0.60% | 12.61% | 2.71% | 1.27% | -23.95% | $158.44B |
Vaxcyte, Inc.PCVX | 20.0% | 0.77% | -4.30% | -8.28% | 0.77% | 22.41% | -8.52% | 67.65% | 40.74% | -49.15% | 115.33% | $8.16B |
| Theme return | — | 0.60% | 1.57% | -2.10% | 0.54% | -66.00% | -18.24% | -97.01% | -63.10% | -20.96% | -1.37% | — |
| Average | 20.0% | -0.60% | -1.57% | 2.62% | -0.30% | 130.55% | 49.57% | 154.19% | 130.70% | 42.08% | 19.12% | $84.64B |
| Median | 20.0% | -1.14% | -1.71% | -3.24% | 0.25% | 22.41% | 0.60% | 67.65% | 30.93% | 1.27% | -23.95% | $75.39B |
| Std Dev | 0.0% | 1.06% | 3.17% | 12.06% | 1.00% | 206.51% | 102.10% | 215.90% | 218.90% | 94.30% | 93.03% | $73.83B |
| Min | 20.0% | -1.87% | -5.18% | -8.28% | -1.86% | 11.71% | -8.52% | 12.61% | 2.71% | -49.15% | -94.24% | $1.72B |
| Max | 20.0% | 0.77% | 3.75% | 25.60% | 0.77% | 542.30% | 253.58% | 583.32% | 567.66% | 211.13% | 142.76% | $179.47B |
| % Positive Tickers | 40.00% | 20.00% | 40.00% | 60.00% | 100.00% | 60.00% | 100.00% | 100.00% | 60.00% | 40.00% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondaryWgt ↓ · Scroll right · Tap headers to sort